Breaking News
September 12, 2024
Mrudula Kulkarni
Piramal Pharma's GHG reduction goals approved by SBTi, targeting 42% emission cuts by 2030.
Mrudula Kulkarni
FDA approves Strides Pharma's generic fluoxetine, enhancing dosage options for depression treatment.
Mrudula Kulkarni
FDA approves Eli Lilly's Ebglyss for eczema in adults and children over 12.
Mrudula Kulkarni
Aarti Drugs & IPCA Labs hit by ransomware, sensitive data stolen and leaked online.
Mrudula Kulkarni